Achilles Corporation
Notice Regarding Recognition of Gain on Sale of Marketable Securities (Extraordinary Income)
Achilles Corporation will record a gain on sale of marketable securities of 1,383 million yen as extraordinary income in the second quarter of the fiscal year ending March 2027. The sales were executed between August 17, 2026 and September 17, 2026. The full-year earnings forecast is maintained, but the company will disclose any necessary revisions due to other factors.
Key Figures
- Gain on sale of marketable securities: 1,383 million yen
- Sale period: 2026-08-17 to 2026-09-17
- Initial estimate: approx. 1,300 million yen
AI要約
Overview and Background
Achilles Corporation conducted sales of marketable securities to reduce holdings of policy-owned shares and improve capital efficiency. As a result, a gain on sale of marketable securities of 1,383 million yen is expected to be recorded. The sales were carried out during the period from August 17, 2026 to September 17, 2026, and five listed securities were subject to the sale.
Outlook and Impact
The above-mentioned gain will be recorded as extraordinary income in the second quarter of the fiscal year ending March 2027. The company intends to maintain its full-year consolidated earnings forecast, but will promptly disclose any revisions if it determines adjustments are necessary due to other factors. This gain has been factored into the full-year earnings upward revision and dividend forecast revision (dividend increase) disclosed on August 7, 2026.
Achilles Corporation
Company overview · Stock price · Financial data · All IR
